Microcirculatory response of skin to benzoic acid and methyl nicotinate in patients with diabetes

Diabetic Medicine

Volumn 17, Issue 2, 2000, Pages 130-133

  Koivukangas, V ^a   Oikarinen, Aarne ^a,b   Salmela, P I ^a   Lahti, A ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Diabetes mellitus; Laser Doppler flowmetry; Microcirculation; Non immunological contact urticaria; Vascular reactivity

Indexed keywords

BENZOIC ACID; NICOTINIC ACID METHYL ESTER;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROCIRCULATION; MICROVASCULATURE; SKIN BLOOD FLOW;

ADULT; BENZOIC ACID; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MICROCIRCULATION; NICOTINIC ACIDS; SKIN;

EID: 0034098258     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00248.x     Document Type: Article

References (22)

1. 1 Tooke JE. Microvasculature in diabetes. Cardiovascular Res 1996; 32:764-771.
2. 2 Flynn MD, Tooke JE. Diabetic neuropathy and microcirculation. Diabetic Med 1995; 12: 298-301.
3. 3 Tooke JE. Microvascular physiology and its clinical relevance with special reference to diabetes. Q J Med 1992; 83: 567-573.
4. 4 Flynn MD, Edmonds ME, Tooke JE, Watkins PJ. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia 1988; 31: 652-656.
5. 5 Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 1993; 100: 721-725.
6. 6 Lahti A. Non-immunologic contact urticaria. In Amin S, Lahti A, Maibach H. eds. Contact Urticaria Syndrome. First Edition. New York: CRC Press, 1997: 5-10.
7. 7 Morrow JD, Parsons WG III, Roberts LJ, II. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 1989; 38: 263-274.
8. 8 Morrow JD, Awad JA, Oates JA, Roberts LJ, II. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 1992; 98: 812-815.
9. 9 Downard CD, Roberts LJII, Morrow JD. Topical benzoic acid induces the increased synthesis of prostaglandin D2 in human skin in vivo. Clin Pharmacol Ther 1995; 57: 441-445.
10. 10 Lahti A. Non-immunologic contact urticaria. Acta Derm Venereol (Stockh) 1980; 60 (Suppl.): 1-49.
11. 11 Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. Impaired microvascular hyperaemic response to minor skin trauma in type 1 diabetes mellitus. Br Med J 1986; 292: 1295-1298.
12. 12 Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995; 38: 1337-1344.
13. 13 Elliot TG, Cockcroft JR, Groop P-H, Viherti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85: 687-693.
14. 14 Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980; 27: 597-604.
15. 15 Parving HH, Viberti GC, Keen H, Lassen NA. Haemodynamic factors in the genesis of diabetic microangiopathy. Metab Clin Exp 1983; 32: 943-949.
16. 16 McNally PG, Watt PAC, Rimmer T, Burden AC, Hearnshaw JR, Thurston H. Impaired contraction of endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci 1994; 87: 31-36.
17. 17 Warren JB, Loi KR, Wilson AJ. PGD2 is an intermediate in agonist-induced nitric oxide release in rabbit skin microcirculation. Am J Physiol 1994; 266 (5: Part 2): H1846-1853.
18. 18 Ruzicka T, Printz MP. Arachidonic acid metabolism in skin: experimental contact dermatitis in guinea pigs. Int Archs Allergy Appl Immunol 1982; 69: 347-352.
19. 19 Urade Y, Ujihara M, Hariguchi Y, Ikai K, Hayaishi O. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells: localization of glutathione-requiring PGD synthetase in histiocytes, dendritic and Kupffer cells in various rat tissues. J Immunol 1989; 143: 2982-2989.
20. 20 Durante W, Sunahara FA, Sen AK. Altered myocardial prostaglandin synthesis in spontaneously diabetic rats. Prostag Leukotr Ess 1989; 38: 81-86.
21. 21 Peredo H, Agostini MD, Gimeno MF, Borda ES. Hypersensitivity to norepinephrine in vasa deferentia from diabetic rats. Possible participation of metabolic products of arachidonic acid. Prostag Leukotr Med 1984; 15: 229-239.
22. 22 Harvey JN, Edmundson AW, Jaffa AA, Martin LL, Mayfield RK. Renal excretion of kallikrem and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia 1992; 35: 857-862.